Mkts

Intellia Therapeutics, Inc.

NASDAQ: NTLA
$10.00+0.48 (+5.04%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
9.3010.39
52-week range
7.9518.48
Today
Open9.34
Previous close10.00
Volume—
Valuation
Market cap1.42B
P/E ratio—
EPS (TTM)-3.36
Income & risk
Dividend / yield—
Beta1.87
Avg volume4.51M
Discussion

NTLA News

Stories mentioning NTLA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue15,04823,01713,78214,24516,62712,8749,1116,957
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development80,73788,65294,74797,035108,427116,877123,380114,207
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(100,532)(98,710)(111,477)(109,996)(120,807)(136,447)(144,770)(139,043)
Interest Income5,2056,4766,7147,4028,60310,63112,12212,422
Interest Expense
Other Expense4,3012,92410,1538,7416,4787,5499,058(7,932)
Pretax Income
Tax Provision
Net Income (Loss)(96,231)(95,786)(101,324)(101,255)(114,329)(128,898)(135,712)(146,975)
Earnings Per Share (Basic)(0.81)(0.88)(0.92)(0.98)(1.10)(1.30)(1.34)(1.52)
Earnings Per Share (Diluted)(0.81)(0.88)(0.92)(0.98)(1.10)(1.30)(1.34)(1.52)
Weighted Average Shares Outstanding (Basic)118,490108,376110,188103,732103,50098,849101,00296,975
Weighted Average Shares Outstanding (Diluted)118,490108,376110,188103,732103,50098,849101,00296,975

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NTLA

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a stock listed on the Nasdaq Stock Market under the ticker symbol NTLA. It last traded at $10.00 (Nov 20, 2026, 4:00 PM ET), up 5.0% on the day. That gives Intellia Therapeutics a market capitalisation of $1.4B.

Over the past 52 weeks NTLA has traded between $7.95 and $18.48.

Revenue for the quarter ended Mar 31, 2026 was $15.0M; a net loss of $96.2M. Revenue was down 9.5% from $16.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$15.0M-$96.2M-639.5%
Dec 31, 2025$23.0M-$95.8M-416.2%
Sep 30, 2025$13.8M-$101.3M-735.2%
Jun 30, 2025$14.2M-$101.3M-710.8%

From Intellia Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…